Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Researchers from University of Essex provide details of new studies and findings in the area of breast cancer
April 2nd, 2009
"We report an approach for multiplex analysis of cancer biomarkers based on the measurement of diagnostic peptides in whole tissue protein digests," scientists writing in the journal Proteomics Clinical Applications report. "Label-free quantitation with MS3 multiple reaction monitoring (MRM) was developed to afford accurate analysis of prospective marker peptides in a panel of breast tumors. This approach provides an economical and robust alternative to stable isotope-based methods," wrote G. Metodieva and colleagues, University of Essex. The researchers concluded: "It is equally applicable to the analysis of samples derived from tissue...
Source: Women's Health Weekly (2009-04-02)
|
